The Science and Technology of Growing Young

The Science and Technology of Growing Young argues that the pace of biomedical innovation is about to change what a normal human lifespan looks like, and that the practical task for most people is to stay healthy long enough to benefit from what is coming. Sergey Young writes as a longevity investor rather than a clinician, and the book is structured as a map of a field he funds and follows closely.

His organising framework is three horizons. The near horizon covers what is available now: better diagnostics, wearable monitoring, early cancer detection, and the unglamorous basics of sleep, movement, nutrition and preventive screening. The far horizon covers technologies under development, including gene editing, cellular reprogramming, organ regeneration and replacement, and artificial intelligence applied to drug discovery. A third, more speculative horizon considers digital approaches to extending life well past current biological limits. The through-line is that individual behaviour buys time, and technology may eventually do the rest.

It suits readers who want an orientation to the longevity landscape — who is working on what, which approaches are closest to clinical use, and how the investment world is thinking about the problem. It is a survey rather than a manual.

On evidence, the near-horizon material is conventional and sound, because it mostly restates established preventive medicine. The far-horizon material is forecasting. Young is describing early-stage science, much of it still in animal models or first-in-human work, and his timelines are optimistic in ways that have not been borne out across the field's history. His own position in the industry shapes which technologies receive attention. None of this makes the book misleading, provided it is read as an informed projection rather than a description of available care. Nothing in the far-horizon chapters should be treated as a treatment option, and claims about specific tests or interventions still warrant individual clinical assessment.